TRT claims on TikTok: separating coaching hype from clinical evidence

What did @therealcoach.katz actually say?

Not much, honestly. The entire transcript is: "I'm gonna die, cause you're gonna die! We're gonna come back!" That is the complete content. There is no medical claim, no protocol recommendation, no hormone data, and no context provided in the caption or hashtags. What we have is a fragment, likely pulled from a longer video or used as a hook to grab attention in the first two seconds of a TikTok.

To be fair to the creator, we cannot evaluate what was not said. The phrase may be hyperbole, motivational rhetoric, or a reference to something discussed elsewhere. But as a standalone piece of content categorized under TRT and testosterone replacement therapy, it raises a fair question: is this the kind of messaging that helps people make informed decisions about hormone therapy? The answer, based on this transcript alone, is no.

Does the science back this up?

There is nothing here to evaluate against science. The statement does not make a falsifiable claim about testosterone, hypogonadism, cardiovascular risk, or any measurable outcome. It cannot be confirmed or denied by a clinical trial.

That said, the framing of "dying and coming back" does echo a real and popular narrative in the TRT space: that low testosterone is a kind of slow death, and hormone optimization is a resurrection. That narrative deserves scrutiny. Research on testosterone replacement in genuinely hypogonadal men, such as the TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine), showed TRT was non-inferior to placebo for major cardiovascular events in men with hypogonadism and elevated cardiovascular risk. That is meaningful. But it does not mean TRT is a fountain of youth for every middle-aged man who feels tired.

What did they get wrong (or right)?

There is nothing technically wrong here because there is technically nothing here. A five-word motivational shout is not a medical claim. But the implicit framing, that TRT is about dying and being reborn, is a marketing trope that can mislead people into thinking hormone therapy is more transformative or universally appropriate than evidence supports.

What the creator got right, in a roundabout way, is that low testosterone is associated with real health consequences. Hypogonadism is linked to reduced bone density, metabolic dysfunction, and reduced quality of life (Bassil et al., 2009, Therapeutics and Clinical Risk Management). For genuinely deficient men, TRT can produce meaningful improvements. But "we're gonna come back" implies a universality that the clinical literature does not support. Not everyone on TRT experiences dramatic transformation, and not everyone with low-normal testosterone is a candidate for treatment.

What should you actually know?

If you landed on this video looking for guidance on TRT, here is what actually matters. Testosterone replacement therapy is a legitimate medical treatment for clinically diagnosed hypogonadism, defined by consistently low serum testosterone paired with symptoms. It is not a performance enhancement tool for everyone who feels sluggish.

The TRAVERSE trial is the most important recent data point. It followed over 5,000 men and found no increased risk of major adverse cardiovascular events with TRT compared to placebo, which addressed a longstanding safety concern. But it also was not a study of healthy men seeking optimization. It was a study of men with confirmed hypogonadism.

• TRT requires proper diagnosis, not just a feeling of fatigue or low libido.
• Baseline bloodwork, including total testosterone, free testosterone, LH, and FSH, is necessary before any treatment decision.
• Side effects including erythrocytosis, testicular atrophy, and fertility suppression are real and require monitoring.
• Motivational language in TRT content often outpaces the actual clinical evidence.